Parallel Advisors
ABVX icon

Parallel Advisors’s Abivax ABVX Stock Holding History

Parallel Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.56K Buy
46
+26
+130% +$3.13K ﹤0.01% 3401
2026
Q2 		$2.66K Sell
20
-49
-71% -$5.55K ﹤0.01% 3449
2026
Q1 		$7.68K Buy
+69
New +$8.17K ﹤0.01% 2876

Other funds holding ABVX

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Syquant Capital SAS
Syquant Capital SAS Paris, France $453M AUM 6.35% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57.1B AUM 43.46% 1-Year Est. Return
Diversify Advisory Services
Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return
Diversify Wealth Management
Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Parallel Advisors's ABVX Position: Q3 2026 in Review

Parallel Advisors increased its Abivax (ABVX) stake by 130% in Q3 2026, buying an estimated $3.13K and bringing the position to 46 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Parallel Advisors first reported a position in ABVX in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.68K in Q1 2026. 65 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Parallel Advisors held 46 shares of Abivax worth $4.56K as of Q3 2026.
  • Parallel Advisors bought 26 Abivax shares in Q3 2026, an estimated $3.13K.
  • Abivax made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3401 holding.
  • Parallel Advisors first reported a position in Abivax in Q1 2026 and has held it in 3 quarters since.
  • Parallel Advisors's Abivax position peaked at $7.68K in Q1 2026.
  • 65 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.